NEWPORT BEACH, Calif., Aug. 02, 2017 -- House of Sillage, known for creating extraordinary fragrances each with their own unique inspiration, proudly presents its newest men’s fragrance, “HOS N.004” – Step into the adrenaline circuit.
|
|||||
Rivaled by none, desired by all. Full of flare and always on the edge, this immortal tale of the burning ambition to win, never takes his eye off the prize. The untamable thrill of a lifetime, HOS N.004 is a confident and methodical blend of Calabrese Bergamot and French Lavender with electrifying undertones of Patchouli and Vanilla Bean. Steal the spotlight but always leave them wanting more. An explosion of glamour and glory, he is a hero in his glistening machine, as he soars above his predecessors and challenges the human capacity for excellence. The best of the best has arrived.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0a7f169a-252c-41a0-bfde-873d4f217b20
HOS N.004 is a truly striking and unique scent designed for the man that exemplifies distinction, masculinity, luxury, and power. This brilliant adventure has no clear challenger. The HOS N.004 bottle holds 75 ml with an MSRP of $285.
For more information about “HOS N.004”, please visit our website at www.HouseofSillage.com
About House of Sillage
House of Sillage is based in California and produced in France. The company creates extraordinary fragrances, which are rivaled only by their breathtaking bottles. Under the guidance of Founder Nicole Mather, House of Sillage dedicates itself to maintaining and surpassing the true definitions of luxury. Visit www.HouseOfSillage.com to learn more.
House of Sillage Tel: +1.949.200.9265 x2313 [email protected]


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs 



